5 November 2020 - The Australian boss of Johnson & Johnson's pharmaceuticals business has joined vaccine experts in warning plans for COVID-19 vaccine distribution are still a work in progress and will involve hurdles.
Johnson & Johnson's Janssen business unit is also developing a COVID-19 vaccine candidate which is currently in phase 3 trials and expected to be available for potential use at the start of next year.